The gene gun: current applications in cutaneous gene therapy
暂无分享,去创建一个
J. Uitto | L. Pulkkinen | J Uitto | M T Lin | L Pulkkinen | K Yoon | K. Yoon | M. Lin | Leena Pulkkinen | Jouni Uitto | Michael T. S. Lin
[1] P. Ingham,et al. The patched gene in development and cancer. , 1998, Current opinion in genetics & development.
[2] Murphy. The cutaneous porphyrias: a review , 1999, The British journal of dermatology.
[3] Massimo Pandolfo,et al. Molecular Basis , 2022 .
[4] I. Leigh,et al. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. , 1999, Human molecular genetics.
[5] W. McLean,et al. Human keratin diseases: , 1996, Experimental dermatology.
[6] R. Purcell,et al. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] H. Iizuka,et al. Structural organization of cornified cell envelopes and alterations in inherited skin disorders , 1998, Experimental dermatology.
[8] S. Rosenberg,et al. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. , 1996, Journal of immunology.
[9] J. Morgan,et al. Biologic aspects of expression of stably integrated transgenes in cells of the skin in vitro and in vivo. , 1999, Proceedings of the Association of American Physicians.
[10] H. van Steeg,et al. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. , 1999, Molecular medicine today.
[11] F. Elgh,et al. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. , 1999, Virology.
[12] C. Eng,et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.
[13] C. Eng. Genetics of Cowden syndrome: through the looking glass of oncology. , 1998, International journal of oncology.
[14] D. Jolly. Viral vector systems for gene therapy. , 1994, Cancer gene therapy.
[15] J. Ott,et al. Exposing the human nude phenotype , 1999, Nature.
[16] A. Gambotto,et al. Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models , 1997, Gene Therapy.
[17] A. Marrogi,et al. In situ use of suicide genes for cancer therapy. , 1996, Seminars in oncology.
[18] S. Bale,et al. Patching Together the Genetics of Gorlin Syndrome , 1998, Journal of cutaneous medicine and surgery.
[19] N. Craddock,et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease , 1999, Nature Genetics.
[20] S. Rosenberg,et al. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. , 1996, Journal of immunology.
[21] N. Yang,et al. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Vile,et al. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. , 1994, Cancer research.
[23] James J. Nordlund,et al. THE PIGMENTARY SYSTEM , 1985 .
[24] I. Mackenzie,et al. Retroviral transduction of murine epidermal stem cells demonstrates clonal units of epidermal structure. , 1997, The Journal of investigative dermatology.
[25] Lee,et al. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. , 1998, Cancer research.
[26] R. Vile,et al. Targeted therapy for malignant melanoma. , 1994, Current opinion in oncology.
[27] D. Mahvi,et al. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. , 1996, Human gene therapy.
[28] T. Klein,et al. Transformation of Microbes, Plants and Animals by Particle Bombardment , 1992, Bio/Technology.
[29] S. Bale,et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis , 1998, Nature Genetics.
[30] D. Curiel,et al. Selected strategies to augment polynucleotide immunization. , 1996, Gene therapy.
[31] J. Fine. Epidermolysis Bullosa. Clinical, Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry , 2000 .
[32] D. Curiel,et al. Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. , 1994, Human gene therapy.
[33] J. Haynes,et al. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery , 1996, Journal of virology.
[34] E. D. Wolf,et al. High-velocity microprojectiles for delivering nucleic acids into living cells , 1987, Nature.
[35] D. Weiner,et al. In vivo protective anti‐HIV immune responses in non‐human primates through DNA immunization , 1996, Journal of medical primatology.
[36] A. Messenger,et al. A mutational hotspot in the 2B domain of human hair basic keratin 6 (hHb6) in monilethrix patients. , 1998, The Journal of investigative dermatology.
[37] A. Rosenberg,et al. Safe and effective regulation of hematocrit by gene gun administration of an erythropoietin-encoding DNA plasmid. , 1999, Human gene therapy.
[38] N. B. Ray,et al. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. , 1998, Vaccine.
[39] D. Richman,et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.
[40] Z. Ram,et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.
[41] J. Uitto,et al. Hemidesmosomal variants of epidermolysis bullosa , 1998 .
[42] W. Bodmer,et al. Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. , 1999, The Journal of investigative dermatology.
[43] Y W Kan,et al. Cloning of a cDNA for steroid sulfatase: frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[44] E. Fuchs,et al. Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Ting,et al. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] L. Goldsmith,et al. Topical application of viral vectors for epidermal gene transfer. , 1997, The Journal of investigative dermatology.
[47] C. Richards,et al. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[48] D. Roop,et al. Epidermis: an attractive target tissue for gene therapy. , 1994, The Journal of investigative dermatology.
[49] M. Lussier,et al. Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. , 1996, Journal of cell science.
[50] E. Lane,et al. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome , 1997, Nature Genetics.
[51] L. Goldsmith,et al. A model for keratinocyte gene therapy: preclinical and therapeutic considerations. , 1996, Proceedings of the Association of American Physicians.
[52] N. Yang,et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[53] O. Evgrafov,et al. Bacterial β‐galactosidase and human dystrophin genes are expressed in mouse skeletal muscle fibers after ballistic transfection , 1997, FEBS letters.
[54] O. V. Tarasenko,et al. [Expression of the human dystrophin gene in mdx mouse skeletal muscles after ballistic transfection]. , 1998, Genetika.
[55] L. Falo,et al. Targeting the skin for genetic immunization. , 1999, Proceedings of the Association of American Physicians.
[56] S. Johnston,et al. Protection against Mycoplasma pulmonis infection by genetic vaccination. , 1995, DNA and cell biology.
[57] T. Tüting,et al. DNA immunization targeting the skin: molecular control of adaptive immunity. , 1998, The Journal of investigative dermatology.
[58] E. Fuchs,et al. Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice , 1993, Molecular and cellular biology.
[59] P. Jahrling,et al. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. , 1998, Virology.
[60] J. Uitto,et al. Cutaneous gene therapy. Principles and prospects. , 2000, Dermatologic clinics.
[61] J. Nordlund,et al. Molecular basis of congenital hypopigmentary disorders in humans: a review. , 1997, Pigment cell research.
[62] J. Garlick,et al. Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[63] T. Pugh,et al. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[64] N. Yang,et al. Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy. , 1999, Journal of immunotherapy.
[65] J. Ott,et al. Alopecia universalis associated with a mutation in the human hairless gene. , 1998, Science.
[66] S. Burdach,et al. Combined chemokine and cytokine gene transfer enhances antitumor immunity , 1996, Nature Medicine.
[67] W. Abler. The Teeth of the Tyrannosaurs , 1999 .
[68] J. Shapiro,et al. Alopecia: unapproved treatments or indications. , 2000, Clinics in dermatology.
[69] J. Uitto,et al. Plectin and human genetic disorders of the skin and muscle , 1996, Experimental dermatology.
[70] E. Nabel,et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[71] N. Yang,et al. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. , 1996, Gene therapy.
[72] W. Kao,et al. Identification of the cornea-specific keratin 12 promoter by in vivo particle-mediated gene transfer. , 1998, Investigative ophthalmology & visual science.
[73] J. Nordlund. The pigmentary system : physiology and pathophysiology , 1998 .
[74] H. Winter,et al. Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix , 1997, Nature Genetics.
[75] Thomas W. White,et al. Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma , 1998, Human Genetics.
[76] S. Johnston,et al. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[77] D. Kelsell,et al. N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. , 1999, Human molecular genetics.
[78] D. Drew,et al. Humoral responses in mice following vaccination with DNA encoding glutathione S‐transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression , 1999, Parasite immunology.
[79] S. Freeman,et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. , 1993, Cancer research.
[80] J. Vogel. A direct in vivo approach for skin gene therapy. , 1999, Proceedings of the Association of American Physicians.
[81] D. Marchuk. Genetic abnormalities in hereditary hemorrhagic telangiectasia , 1998, Current opinion in hematology.
[82] D. Roop,et al. Transduction of a preselected population of human epidermal stem cells: consequences for gene therapy. , 1999, Proceedings of the Association of American Physicians.
[83] D. Tang,et al. Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.